Skip to main content

Ryan Arthur F's Form 4 filing

Regeneron Pharmaceuticals, Inc. (REGN) · filed Jul 2, 2024

Accession no.
0001968202-24-000105
Filed
Jul 2, 2024
Trade date
Jul 1, 2024
Filing delay
1 day
Rule 10b5-1 plan
Checked

This filing lists 19 non-derivative transactions. Open-market sales total $105.9K. It was filed 1 day after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Ryan Arthur FCIK 0001187443Director

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Jul 1, 2024Common StockSSaleDisposed−3$1,047.11−$3,141.3317,979Direct
Jul 1, 2024Common StockSSaleDisposed−2$1,050.87−$2,101.7417,977Direct
Jul 1, 2024Common StockSSaleDisposed−7$1,051.58F2−$7,361.0617,970Direct
Jul 1, 2024Common StockSSaleDisposed−6$1,052.19F3−$6,313.1417,964Direct
Jul 1, 2024Common StockSSaleDisposed−8$1,053.60F4−$8,428.817,956Direct
Jul 1, 2024Common StockSSaleDisposed−1$1,054.25−$1,054.2517,955Direct
Jul 1, 2024Common StockSSaleDisposed−2$1,056.81−$2,113.6217,953Direct
Jul 1, 2024Common StockSSaleDisposed−2$1,057.64−$2,115.2817,951Direct
Jul 1, 2024Common StockSSaleDisposed−17$1,058.49F5−$17,994.3317,934Direct
Jul 1, 2024Common StockSSaleDisposed−3$1,059.36F6−$3,178.0817,931Direct
Jul 1, 2024Common StockSSaleDisposed−3$1,060.14−$3,180.4217,928Direct
Jul 1, 2024Common StockSSaleDisposed−3$1,061.73F7−$3,185.1917,925Direct
Jul 1, 2024Common StockSSaleDisposed−19$1,062.31F8−$20,183.8917,906Direct
Jul 1, 2024Common StockSSaleDisposed−5$1,063.87F9−$5,319.3517,901Direct
Jul 1, 2024Common StockSSaleDisposed−7$1,064.55F10−$7,451.8517,894Direct
Jul 1, 2024Common StockSSaleDisposed−3$1,065.52F11−$3,196.5617,891Direct
Jul 1, 2024Common StockSSaleDisposed−4$1,066.59F12−$4,266.3617,887Direct
Jul 1, 2024Common StockSSaleDisposed−3$1,067.51F13−$3,202.5317,884Direct
Jul 1, 2024Common StockSSaleDisposed−2$1,068.09−$2,136.1817,882Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F2

Represents volume-weighted average price of sales of 7 shares of Company stock on July 1, 2024 at prices ranging from $1,051.03 to $1,051.89. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on July 1, 2024 at each separate price.

Referenced by the price of 1 transaction in Table I.

F3

Represents volume-weighted average price of sales of 6 shares of Company stock on July 1, 2024 at prices ranging from $1,052.10 to $1,052.25. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on July 1, 2024 at each separate price.

Referenced by the price of 1 transaction in Table I.

F4

Represents volume-weighted average price of sales of 8 shares of Company stock on July 1, 2024 at prices ranging from $1,053.32 to $1,053.70. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on July 1, 2024 at each separate price.

Referenced by the price of 1 transaction in Table I.

F5

Represents volume-weighted average price of sales of 17 shares of Company stock on July 1, 2024 at prices ranging from $1,058.08 to $1,058.91. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on July 1, 2024 at each separate price.

Referenced by the price of 1 transaction in Table I.

F6

Represents volume-weighted average price of sales of 3 shares of Company stock on July 1, 2024 at prices ranging from $1,059.22 to $1,059.44. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on July 1, 2024 at each separate price.

Referenced by the price of 1 transaction in Table I.

F7

Represents volume-weighted average price of sales of 3 shares of Company stock on July 1, 2024 at prices ranging from $1,061.69 to $1,061.75. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on July 1, 2024 at each separate price.

Referenced by the price of 1 transaction in Table I.

F8

Represents volume-weighted average price of sales of 19 shares of Company stock on July 1, 2024 at prices ranging from $1,062.14 to $1,062.90. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on July 1, 2024 at each separate price.

Referenced by the price of 1 transaction in Table I.

F9

Represents volume-weighted average price of sales of 5 shares of Company stock on July 1, 2024 at prices ranging from $1,063.84 to $1,063.88. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on July 1, 2024 at each separate price.

Referenced by the price of 1 transaction in Table I.

F10

Represents volume-weighted average price of sales of 7 shares of Company stock on July 1, 2024 at prices ranging from $1,064.18 to $1,064.88. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on July 1, 2024 at each separate price.

Referenced by the price of 1 transaction in Table I.

F11

Represents volume-weighted average price of sales of 3 shares of Company stock on July 1, 2024 at prices ranging from $1,065.44 to $1,065.68. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on July 1, 2024 at each separate price.

Referenced by the price of 1 transaction in Table I.

F12

Represents volume-weighted average price of sales of 4 shares of Company stock on July 1, 2024 at prices ranging from $1,066.31 to $1,066.86. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on July 1, 2024 at each separate price.

Referenced by the price of 1 transaction in Table I.

F13

Represents volume-weighted average price of sales of 3 shares of Company stock on July 1, 2024 at prices ranging from $1,067.41 to $1,067.72. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on July 1, 2024 at each separate price.

Referenced by the price of 1 transaction in Table I.

Read the full filing on SEC EDGAR (opens in a new tab)